News
Company expects controlled-release gliclazide tablets to generate $15 million in annual revenues BEIJING, Oct. 19 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback